Search results
Novavax seeks FDA approval for COVID booster
ABC News via Yahoo News· 2 years agoNovavax has submitted an application to the Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine as a booster in adults...
Novavax Covid vaccine becomes fourth to receive FDA approval
The Independent via Yahoo News· 2 years agoThe Food and Drug Administration authorised the use of Novavax Covid-19 vaccine for adults on...
Novavax Inc (NVAX) Reports Mixed Q3 Results Amid Cost Reduction Efforts and Vaccine Approvals
GuruFocus.com via Yahoo Finance· 5 months agoNovavax Inc (NASDAQ:NVAX) reported total revenue of $187 million for Q3 2023, a significant decrease...
FDA authorizes Novavax's updated COVID vaccine
CBS News via Yahoo News· 6 months agoThe Food and Drug Administration announced Tuesday it had authorized Novavax's updated COVID-19 vaccine, adding a third option for Americans ages 12 and...
Novavax nears FDA advisory meeting date
Yahoo Finance· 2 years agoNovavax signaled a positive outlook for its vaccine pipeline Wednesday with announcements at the World Vaccine Congress and an update on its COVID-19...
FDA Committee Proposes EUA Nod to Novavax's (NVAX) COVID Jab
Zacks via Yahoo Finance· 2 years agoAn FDA advisory committee supports granting emergency use authorization to Novavax's (NVAX) COVID-19...
FDA authorizes Novavax's Covid vaccine
NBC Universal via AOL· 2 years agoThe Food and Drug Administration on Wednesday authorized Novavax’s protein-based Covid vaccine for adults, providing Americans with an alternative to the...
Novavax CEO eyes next batch of COVID-19 vaccines after CDC approval
Yahoo Finance via AOL· 2 years agoNovavax passed the finish line to gain authorization for its COVID-19 vaccine, and its first...
Novavax' Sees Conditional Approval Of COVID-19 Vaccine Booster In Australia As US FDA Delays Its...
Benzinga via Yahoo Finance· 2 years agoThe Australian regulatory authority has conditionally approved Novavax Inc's (NASDAQ: NVAX)...
Novavax Stock Looks Like a Good Value With Its New Combined Vaccine
InvestorPlace via Yahoo Finance· 2 years agoNovavax (NVAX) is down from a peak of $217.32 on Dec. 17 to just $53.69, reaching a new low. The...